Mark Poznansky,James Markmann,Timothy Brauns,Marinko Sremac,Nicolas Chronos,Suren Chavan
申请号：
US15496573
公开号：
US20170304400A1
申请日:
2017.04.25
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This disclosure is directed to methods of treating a subject with a fibrotic or fibroproliferative disease, comprising administering to the subject a composition comprising an effective amount of an anti-fibrosis agent, e.g., a CXCR4 and/or CXCR7 binding agent, such as CXCL12.
